NCT07410455Phase 2Not yet recruiting

An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome

Study sponsor: Can-Fite BioPharma

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-08-31Estimated
Enrollment · participants5Estimated
Source updated2026-02-18Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.